NCT03921671 2024-05-29
RELEVENT
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
Clinical Trials
5 trialsNCT05407649 2022-06-07
Abscopal Effect of Radiotherapy in Combination With rhGM-CSF for Advanced Thymic Epithelial Tumours
Shanghai Cancer Hospital, China
Phase 2 Unknown
NCT03663764 2021-12-10
Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor
Sun Yat-sen University
Phase 2 Unknown
NCT02364076 2019-12-13
Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma
Georgetown University
Phase 2 Unknown
NCT03466827 2018-03-15
TET-SEL
Rigshospitalet, Denmark
Phase 2 Unknown